Clofarabine plus cytarabine compared to cytarabine alone in older patients with relapsed or refractory (R/R) acute myelogenous leukemia (AML): Results from the phase III CLASSIC 1 trial.
暂无分享，去创建一个
R. Collins | P. Hari | M. Maris | H. Kantarjian | F. Ravandi | S. Eckert | G. Schiller | D. Rizzieri | T. Kovacsovics | R. Stuart | K. Seiter | S. Goldberg | M. Wetzler | E. Wang | S. Faderl | D. Avigan | M. Jagasia | D. Huebner | S. Ganguly | M. Craig